Jarislowsky, Fraser Ltd’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$83.5M Sell
450,506
-22,340
-5% -$3.83M 0.46% 55
2025
Q2
$72.2M Sell
472,846
-5,727
-1% -$880K 0.41% 54
2025
Q1
$79.4M Sell
478,573
-10,000
-2% -$1.56M 0.5% 50
2024
Q4
$70.7M Sell
488,573
-23,399
-5% -$3.63M 0.41% 54
2024
Q3
$83M Sell
511,972
-23,656
-4% -$3.77M 0.46% 52
2024
Q2
$78.3M Sell
535,628
-119,285
-18% -$17.7M 0.48% 52
2024
Q1
$104M Sell
654,913
-27,110
-4% -$4.32M 0.59% 45
2023
Q4
$107M Sell
682,023
-6,896
-1% -$1.06M 0.63% 41
2023
Q3
$107M Sell
688,919
-10,448
-1% -$1.72M 0.7% 41
2023
Q2
$116M Sell
699,367
-7,240
-1% -$1.17M 0.69% 40
2023
Q1
$110M Sell
706,607
-17,870
-2% -$2.89M 0.68% 42
2022
Q4
$128M Sell
724,477
-15,668
-2% -$2.71M 0.84% 39
2022
Q3
$121M Sell
740,145
-13,632
-2% -$2.31M 0.84% 37
2022
Q2
$134M Sell
753,777
-24,670
-3% -$4.4M 0.85% 36
2022
Q1
$138M Sell
778,447
-29,168
-4% -$4.96M 0.74% 39
2021
Q4
$138M Sell
807,615
-37,285
-4% -$6.1M 0.64% 40
2021
Q3
$136M Sell
844,900
-34,038
-4% -$5.81M 0.66% 39
2021
Q2
$145M Sell
878,938
-35,101
-4% -$5.81M 0.68% 38
2021
Q1
$150M Sell
914,039
-33,435
-4% -$5.41M 0.74% 36
2020
Q4
$149M Sell
947,474
-32,175
-3% -$4.75M 0.76% 36
2020
Q3
$146M Sell
979,649
-386,549
-28% -$57.2M 0.86% 33
2020
Q2
$192M Buy
1,366,198
+61,171
+5% +$8.91M 1.2% 25
2020
Q1
$171M Buy
1,305,027
+1,411
+0.1% +$200K 1.25% 24
2019
Q4
$190M Sell
1,303,616
-9,681
-0.7% -$1.31M 1.01% 27
2019
Q3
$170M Sell
1,313,297
-10,861
-0.8% -$1.43M 0.96% 28
2019
Q2
$184M Sell
1,324,158
-25,174
-2% -$3.48M 1.12% 21
2019
Q1
$189M Sell
1,349,332
-97,380
-7% -$13M 1.18% 20
2018
Q4
$187M Sell
1,446,712
-17,980
-1% -$2.51M 1.28% 20
2018
Q3
$205M Sell
1,464,692
-59,748
-4% -$7.94M 1.27% 20
2018
Q2
$185M Sell
1,524,440
-3,260
-0.2% -$407K 1.11% 20
2018
Q1
$196M Sell
1,527,700
-36,117
-2% -$4.88M 1.22% 19
2017
Q4
$218M Sell
1,563,817
-39,783
-2% -$5.54M 1.27% 19
2017
Q3
$208M Sell
1,603,600
-2,242
-0.1% -$297K 1.25% 18
2017
Q2
$212M Sell
1,605,842
-13,379
-0.8% -$1.71M 1.34% 17
2017
Q1
$202M Sell
1,619,221
-61,221
-4% -$7.31M 1.28% 18
2016
Q4
$194M Sell
1,680,442
-18,489
-1% -$2.14M 1.24% 18
2016
Q3
$201M Sell
1,698,931
-39,927
-2% -$4.84M 1.35% 18
2016
Q2
$211M Sell
1,738,858
-66,150
-4% -$7.52M 1.47% 18
2016
Q1
$195M Sell
1,805,008
-92,094
-5% -$9.53M 1.37% 18
2015
Q4
$195M Sell
1,897,102
-337,317
-15% -$33.9M 1.48% 17
2015
Q3
$209M Sell
2,234,419
-7,686
-0.3% -$744K 1.57% 15
2015
Q2
$219M Sell
2,242,105
-25,670
-1% -$2.57M 1.49% 16
2015
Q1
$228M Sell
2,267,775
-76,040
-3% -$7.73M 1.52% 14
2014
Q4
$245M Sell
2,343,815
-49,936
-2% -$5.26M 1.52% 15
2014
Q3
$255M Sell
2,393,751
-49,694
-2% -$5.15M 1.53% 14
2014
Q2
$256M Sell
2,443,445
-82,951
-3% -$8.38M 1.43% 17
2014
Q1
$248M Sell
2,526,396
-122,650
-5% -$11.4M 1.44% 18
2013
Q4
$243M Sell
2,649,046
-66,833
-2% -$6.16M 1.36% 18
2013
Q3
$235M Sell
2,715,879
-70,641
-3% -$6.34M 1.38% 18
2013
Q2
$239M Buy
+2,786,520
New +$236M 1.45% 18

Other funds holding JNJ

Jarislowsky, Fraser Ltd's JNJ Position: Q3 2025 in Review

Jarislowsky, Fraser Ltd reduced its Johnson & Johnson (JNJ) stake by 4.7% in Q3 2025, selling an estimated $3.83M and leaving 450,506 shares worth $83.5M. The position accounts for 0.46% of the portfolio, ranked #55.

Jarislowsky, Fraser Ltd first reported a position in JNJ in Q2 2013 and has held it in 50 quarters since. The position peaked at $256M in Q2 2014. 4,188 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Jarislowsky, Fraser Ltd held 450,506 shares of Johnson & Johnson worth $83.5M as of Q3 2025.
  • Jarislowsky, Fraser Ltd sold 22,340 Johnson & Johnson shares in Q3 2025, an estimated $3.83M.
  • Johnson & Johnson made up 0.46% of Jarislowsky, Fraser Ltd's portfolio in Q3 2025, its #55 holding.
  • Jarislowsky, Fraser Ltd first reported a position in Johnson & Johnson in Q2 2013 and has held it in 50 quarters since.
  • Jarislowsky, Fraser Ltd's Johnson & Johnson position peaked at $256M in Q2 2014.
  • 4,188 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q3 2025, filed 21 Oct 2025.